Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
about
Developments in FTICR-MS and Its Potential for Body Fluid SignaturesSolid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomicsApplication of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.
P2860
Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Case-controlled identification ...... d the potential for screening.
@ast
Case-controlled identification ...... d the potential for screening.
@en
type
label
Case-controlled identification ...... d the potential for screening.
@ast
Case-controlled identification ...... d the potential for screening.
@en
prefLabel
Case-controlled identification ...... d the potential for screening.
@ast
Case-controlled identification ...... d the potential for screening.
@en
P2093
P2860
P356
P1433
P1476
Case-controlled identification ...... d the potential for screening.
@en
P2093
A Huijbers
A M Deelder
B J Mertens
R A E M Tollenaar
W E Mesker
Y E M van der Burgt
P2860
P304
P356
10.1111/CODI.12782
P577
2014-11-01T00:00:00Z